DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting

BACKGROUND: Daily directly-observed therapy (DOT) is recommended for rifampicin-resistant tuberculosis (RR-TB) patients throughout treatment. We assessed the impact of self-administered treatment (SAT) in a South African township with high rates of RR-TB and HIV. METHODS: Community-supported SAT for...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohr, Erika, Daniels, Johnny, Beko, Busisiwe, Isaakidis, Petros, Cox, Vivian, Steele, Sarah Jane, Muller, Odelia, Snyman, Leigh, De Azevedo, Virginia, Shroufi, Amir, Trivino Duran, Laura, Hughes, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436852/
https://www.ncbi.nlm.nih.gov/pubmed/28542441
http://dx.doi.org/10.1371/journal.pone.0178054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436852/
https://www.ncbi.nlm.nih.gov/pubmed/28542441
http://dx.doi.org/10.1371/journal.pone.0178054

Ejemplares similares